Free Trial

Provectus Biopharmaceuticals (PVCT) SEC Filings & 10K Form

Provectus Biopharmaceuticals logo
$0.11
0.00 (0.00%)
(As of 11/4/2024 ET)

Recent Provectus Biopharmaceuticals SEC Filings

DateFilerForm TypeView
10/17/2024
11:31 AM
Pershing Edward (Reporting)
Provectus Biopharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/30/2024
6:58 PM
Bailey Webster (Reporting)
Provectus Biopharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/30/2024
7:01 PM
Lacey John III (Reporting)
Provectus Biopharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/30/2024
7:06 PM
Pershing Edward (Reporting)
Provectus Biopharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/30/2024
5:56 PM
Pershing Edward (Reporting)
Provectus Biopharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/30/2024
5:58 PM
Provectus Biopharmaceuticals (Issuer)
Rodrigues Dominic (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/20/2024
4:21 PM
Pershing Edward (Reporting)
Provectus Biopharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/30/2024
8:54 AM
Pershing Edward (Reporting)
Provectus Biopharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/27/2024
10:15 AM
Pershing Edward (Reporting)
Provectus Biopharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/19/2024
2:06 PM
Provectus Biopharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/14/2024
6:23 PM
Morris Jeffrey Allen (Filed by)
Provectus Biopharmaceuticals (Subject)
Form SC 13G
08/14/2024
6:19 PM
Morris Jeffrey Allen (Reporting)
Provectus Biopharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/13/2024
12:21 PM
Provectus Biopharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/09/2024
2:31 PM
Pershing Edward (Reporting)
Provectus Biopharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/23/2024
4:20 PM
Provectus Biopharmaceuticals (Issuer)
Rodrigues Dominic (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/22/2024
2:24 PM
Pershing Edward (Reporting)
Provectus Biopharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/19/2024
12:02 PM
Pershing Edward (Reporting)
Provectus Biopharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/17/2024
2:50 PM
Provectus Biopharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/03/2024
6:29 PM
Pershing Edward (Filed by)
Provectus Biopharmaceuticals (Subject)
Form SC 13D
07/02/2024
9:37 AM
Pershing Edward (Reporting)
Provectus Biopharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/01/2024
5:46 PM
Pershing Edward (Reporting)
Provectus Biopharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2024
2:41 PM
Provectus Biopharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/21/2024
12:56 PM
Provectus Biopharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/21/2024
1:08 PM
Pershing Edward (Reporting)
Provectus Biopharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2024
8:30 AM
Provectus Biopharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/20/2024
5:03 AM
Provectus Biopharmaceuticals (Filer)
Form DEFA14A
06/17/2024
4:58 PM
Pershing Edward (Reporting)
Provectus Biopharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/28/2024
4:32 PM
Pershing Edward (Reporting)
Provectus Biopharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/14/2024
1:43 PM
Provectus Biopharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/13/2024
12:33 PM
Pershing Edward (Reporting)
Provectus Biopharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/09/2024
9:54 AM
Provectus Biopharmaceuticals (Filer)
Form ARS
05/06/2024
12:56 PM
Provectus Biopharmaceuticals (Filer)
Form DEF 14A
05/06/2024
12:57 PM
Provectus Biopharmaceuticals (Filer)
Form DEFA14A
04/30/2024
11:20 AM
Pershing Edward (Reporting)
Provectus Biopharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/29/2024
12:10 PM
Provectus Biopharmaceuticals (Filer)
Form 10-K/A
04/26/2024
10:48 AM
Provectus Biopharmaceuticals (Filer)
Form PRE 14A
04/26/2024
8:00 AM
Pershing Edward (Reporting)
Provectus Biopharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/22/2024
10:08 AM
Pershing Edward (Reporting)
Provectus Biopharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/16/2024
3:58 PM
Provectus Biopharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/15/2024
2:45 PM
Pershing Edward (Reporting)
Provectus Biopharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/09/2024
3:31 PM
Pershing Edward (Reporting)
Provectus Biopharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
[Urgent] Starlink Set For The Largest IPO In History? (Ad)

He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again with Tesla… which is up more than 19,500% since 2010. For perspective, that turns $100 invested into almost $20,000! And now, Elon could be set to do it for the third and final time… with what might be his biggest breakthrough yet. And for the first time ever, you have the rare chance to profit BEFORE the upcoming IPO.

Click here now for the urgent details on this hidden play.
03/28/2024
1:35 PM
Provectus Biopharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/27/2024
11:10 AM
Provectus Biopharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/26/2024
3:48 PM
Provectus Biopharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/26/2024
3:49 PM
Pershing Edward (Reporting)
Provectus Biopharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/22/2024
9:58 AM
Pershing Edward (Reporting)
Provectus Biopharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2024
4:29 PM
Pershing Edward (Reporting)
Provectus Biopharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/29/2024
8:22 AM
Provectus Biopharmaceuticals (Issuer)
Raines Heather (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/28/2024
2:16 PM
Pershing Edward (Reporting)
Provectus Biopharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/28/2024
1:12 PM
Pershing Edward (Reporting)
Provectus Biopharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/22/2024
8:30 AM
Provectus Biopharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/20/2024
10:12 AM
Pershing Edward (Reporting)
Provectus Biopharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/16/2024
4:54 PM
Pershing Edward (Reporting)
Provectus Biopharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/15/2024
7:05 AM
Provectus Biopharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/06/2024
2:16 PM
Provectus Biopharmaceuticals (Issuer)
Raines Heather (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/01/2024
4:29 PM
Pershing Edward (Reporting)
Provectus Biopharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/29/2024
3:21 PM
Pershing Edward (Reporting)
Provectus Biopharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/12/2024
1:55 PM
Pershing Edward (Reporting)
Provectus Biopharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/22/2023
10:39 AM
Pershing Edward (Reporting)
Provectus Biopharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/04/2023
11:49 AM
Pershing Edward (Reporting)
Provectus Biopharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/30/2023
5:51 PM
Pershing Edward (Reporting)
Provectus Biopharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/15/2023
4:23 PM
Pershing Edward (Reporting)
Provectus Biopharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/14/2023
10:35 AM
Provectus Biopharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/13/2023
8:00 AM
Pershing Edward (Reporting)
Provectus Biopharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (OTCMKTS:PVCT) was last updated on 11/5/2024 by MarketBeat.com Staff
From Our Partners